Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study
Abstract Background The prognostic role of the V600E mutation of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) in metastatic colorectal cancer (mCRC) is well established, but the therapeutic regimen targeting this disease is lacking. This study aimed to analyze the clinicopathologic features...
Main Authors: | Xicheng Wang, Qing Wei, Jing Gao, Jian Li, Jie Li, Jifang Gong, Yanyan Li, Lin Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | Chinese Journal of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40880-017-0247-y |
Similar Items
-
Clinicopathologic Features and Prognosis of BRAF Mutated Colorectal Cancer Patients
by: Wen-Long Guan, et al.
Published: (2020-11-01) -
BRAF mutation is associated with poor clinicopathological outcomes in colorectal cancer: A meta-analysis
by: Yujie Li, et al.
Published: (2017-01-01) -
BRAF Non-V600E Mutated Metastatic Colorectal Cancer in a Young Patient: Discussion from a Case Report
by: Laure Moisset, et al.
Published: (2019-06-01) -
The Role of BRAF in Metastatic Colorectal Carcinoma–Past, Present, and Future
by: Angela Djanani, et al.
Published: (2020-11-01) -
<i>KRAS</i> and <i>BRAF</i> Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study
by: Nuria Garcia-Carbonero, et al.
Published: (2020-01-01)